RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-746-05

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
February 28, 2025
Posted
March 19, 2025
Recall Number
D-0271-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
11,125 bottles.
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

Distribution

Nationwide

Lot / Code Info

Lot#: 240098C, Expiration: 01/2027.

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls